Skip to main content
Eurofins-Cerep logo

Eurofins-Cerep — Investor Relations & Filings

Ticker · ALECR ISIN · FR0013256518 LEI · 9695004C9D3ZX7FTZY16 PA Professional, scientific and technical activities
Open in API
Filings indexed 53 across all filing types
Latest filing 2009-06-17 Regulatory Filings
Country FR France
Listing PA ALECR

About Eurofins-Cerep

https://www.eurofins.fr

Eurofins-Cerep is a Contract Research Organization (CRO) specializing in pre-clinical drug discovery services. The company provides solutions for in vitro drug profiling and screening in pharmacology, supporting pharmaceutical, biopharmaceutical, and biotechnology companies in the early stages of new drug development. Its services focus on delivering critical data regarding the biological activity and potential liabilities of chemical compounds, which aids clients in the identification and optimization of promising drug candidates before they proceed to clinical trials.

Recent filings

Filing Released Lang Actions
Cerep and Servier establish a new collaboration agreement for drug discovery and lead optimization
Regulatory Filings Classification · 95% confidence The document is explicitly titled as a 'press release' announcing a 'collaboration agreement' between two companies (Cerep and Servier) for drug discovery. It details the terms of this business arrangement, includes quotes from executives, and concludes with contact information and standard forward-looking statements typical of corporate news releases. This content does not fit the definitions for formal financial reports (10-K, IR, ER, AR), shareholder actions (AGM-R, DVA), or specific regulatory filings. Since it is a general corporate announcement regarding a business development that doesn't fit the more specific categories like M&A (TAR) or Financing (CAP), the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous corporate announcements not covered elsewhere.
2009-06-17 English
Cerep announces Kinase profiling agreement with Lilly
Regulatory Filings Classification · 90% confidence The document is explicitly labeled as a "press release" dated June 15, 2009, announcing a specific business event: a kinase profiling agreement between Cerep SA and Eli Lilly and Company. This content—a specific, non-periodic business development announcement—does not fit the definitions for major periodic reports (10-K, IR, ER), shareholder materials (AGM-R, DEF 14A), or specific financial actions (CAP, DIV, POS). It is a general corporate announcement regarding business operations and collaborations. Since there is no specific category for a general business/collaboration press release, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous regulatory announcements that do not fit elsewhere.
2009-06-15 English
Cerep et Lilly signent un accord de profilage sur kinases
Regulatory Filings Classification · 86% confidence The document is a press release dated June 15, 2009, announcing a new agreement between Cerep SA and Eli Lilly and Company regarding kinase profiling services. This type of announcement, detailing a specific business development, partnership, or contract signing, does not fit neatly into the defined categories like 10-K (Annual Report), ER (Earnings Release), or IR (Interim Report). It is a general business update. Since it is not a report announcement (RPA) but the content of the announcement itself, and it doesn't relate to M&A (TAR), Director's Dealing (DIRS), or Capital changes (CAP), the most appropriate fallback category for a specific, non-standard regulatory or business announcement is 'Regulatory Filings' (RNS), as it serves as a general disclosure.
2009-06-15 French
Assemblée générale mixte (ordinaire et extraordinaire) du vendredi 19 juin 2009 - Modalités de mise à disposition des documents préparatoires
AGM Information Classification · 99% confidence The document text explicitly mentions 'Assemblée générale mixte (ordinaire et extraordinaire)' (Combined Ordinary and Extraordinary General Meeting) scheduled for June 19, 2009. It details the modalities for making preparatory documents available to shareholders, referencing the 'avis de réunion valant avis de convocation' (notice of meeting serving as notice of convocation). This content is directly related to the formal procedures and materials surrounding an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2009-05-15 French
Rapport financier annuel 2008
Annual Report Classification · 100% confidence The document is titled 'rapport financier annuel 2008' (Annual Financial Report 2008) and includes an 'attestation du responsable' (management certification) and a 'rapport de gestion' (management report). It covers the company's activities, financial situation, and business outlook for the fiscal year 2008. As it is a comprehensive annual report containing financial statements and management analysis, it is classified as a 10-K (Annual Report). FY 2008
2009-05-13 French
First quarter 2009 sales revenues
Earnings Release Classification · 95% confidence The document is a press release titled 'First quarter 2009 sales revenues' issued by Cerep. It provides key financial highlights for the first quarter, including consolidated sales revenue figures, cash position, and business updates. While it contains financial data, it is a short, high-level summary release rather than a comprehensive interim financial report (which would include full financial statements). Therefore, it is classified as an Earnings Release (ER). Q1 2009
2009-05-04 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.